The potential role of perfluorochemicals (PFCS) in diagnostic imaging

Artificial Cells, Blood Substitutes, and Biotechnology

Volumn 22, Issue 2, 1994, Pages 295-313

  Mattrey, Robert F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGRAPHY; BLOOD VESSELS; CELLS; CHEMICALS; COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; TISSUE; ULTRASONIC IMAGING; X RAYS;

COLOR DOPPLER IMAGING; DIAGNOSTIC AGENT; PERFLUOROCHEMICALS; RADIOPAQUE; STANDARD RADIOGRAPHY; X RAY COMPUTED TOMOGRAPHY;

FLUORINE COMPOUNDS;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; PERFLUORO COMPOUND;

ANGIOGRAPHY; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC IMAGING; EMULSION; INTRAVENOUS DRUG ADMINISTRATION; LIVER; LUNG; LYMPH NODE; OXYGEN TISSUE LEVEL; RADIOGRAPHY; RETICULOENDOTHELIAL SYSTEM; SPLEEN; TISSUE PERFUSION; X IRRADIATION;

DIAGNOSTIC IMAGING; FLUOROCARBONS; HUMAN; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 0028439325     PISSN: 10731199     EISSN: 15324184     Source Type: Journal    
DOI: 10.3109/10731199409117422     Document Type: Article

References (50)

1. D.S.L. Slinn, SW Green. Fluorocarbon Fluids For Use in the Electronics Industry. In. Banks RE ed. Preparation, Properties, and Industrial Applications of Organofluorine Compounds. Chischester, England: Ellis Horwood Limited, 45-82 (1982)
2. F.A. Ubel, SD Sorenson, DE Roach. Health Status of Plant Workers Exposed to Fluorochemicals: A Preliminary Report. Amer. Industrial Hygiene Assoc Jour 41:5 84-5 89 (1980)
3. J.G. Riess. Reassessment of Criteria for the Selection of Perfluorochemicals for Second-Generation Blood Substitutes: Analysis of Structure/Property Relationships. Artificial Organs 8:44-56 (1984).
4. R. Naito, K Yokohama. In: The Green Cross Corp Technical Information Series, no. 5. Perfluorochemical Blood Substitutes FC-43 Emulsion, Fluosol-DA 20% and 35% for Preclinical Studies as a Candidate for Erythrocyte Substitution. 37,84,161-169 (1981).
5. K.K. Tremper, AE Freidman, EM Levine, et al. The Preoperative Treatment of Severely Anemic Patients With a Perfluorochemical Oxygen-Transport Fluid, Fluosol-DA. N Engl J Med 307:277-283 (1982).
6. J.N. Bruneton, MN Falewee, E Francois, et al. Spleen, and Vessels: Preliminary Clinical Results of CT with Perfluorooctylbromide. Radiology 170:179-183(1989).
7. S.L. Wootton, BD Coley, S.W. Hilton, et al. Value of Brominated Fluorocarbons for the Radiographic diagnosis of Small Bowel Obstruction: Comparison with other Contrast Agents in Rats. AJR in press
8. M.R. Wolfson, RG Stern, N Kechner, KM Sekins, TH Shaffer. Utility of a Perlfluorochemical Liquid for Pulmonary Diagnostic Imaging. ISBS 1993, San Diego. These Proceedings
9. R.F. Mattrey: Perfluorooctylbromide: A New Contrast Agent for CT, Sonography, and MR Imaging: Amer J Roentgenology. 152:247-252 (1989).
10. R.F. Mattrey, P Hajek, V Gylys-Morin, et al. Perfluorochemicals as Gastrointestinal Contrast Agents for MRI: Preliminary Studies in Rats and Man. AJR 148:1259-1263 (1987).
11. D.J. Schumacher, GC Steinbach, S Keane, et al. Comparison of Artifacts Generated by Oral MRI Contrast Agents in-vitro. AUR, Lake Buena Vista, FL, 3/91. Invest Radiol. 26:1125 (1991)
12. D.L. Rubin, HH Muller, M Nino-Murcia, et al. Intraluminal Contrast Enhancement and MR Visualization of the Bowel Wall: Efficacy of PFOB. JMRI 1:371-380(1991).
13. S.S. Eilenberg, VM Tartar, RF Mattrey. Reducing Magnetic Susceptibility Differences Using Liquid Fluorocarbon Pads (Sat Pad): Results with Spectral Presaturation of Fat. ISBS 1993, San Diego. These Proceedings
14. L.C. Clark, JL Ackerman, SR Thomas, RW Millard. High Contrast Tissue and Blood Oxygen Imaging Based on Fluorocarbon 19F NMR Relaxation. Magn Reson Med 1:135-136 (1984)
15. M. Le Blanc, JG Riess. Artificial Blood Substitutes Based on Perfluorochemicals. In: Banks RE ed. Preparation, Properties, and Industrial Applications of Organofluorine Compounds. Chischester, England: Ellis Horwood Limited, 83-138 (1982)
16. R.P. Mason. Non-invasive Physiology: 19F NMR of Perfluorocarbons. ISBS 1993, San Diego. These Proceedings
17. Q. Guo, RF Mattrey, MS Guclu, et al. Monitoring OF p02 by Spin-Spin Relaxation Rate 1/T2 of 19F in a Rabbit Abscess Model. ISBS 1993, San Diego. These Proceedings
18. J.M. Canty Jr, RM Judd, AS Brody, FJ Klocke. First-pass Entry of Nonionic Contrast Agent Into the Myocardial Extravascular Space: Effects on Radiographic Estimates of Transit-time and Blood Volume. Circulation 84:2071-8(1991).
19. R.K. Jain. Determinants of Tumor Blood Flow: a Review. Cancer Res 48:2641-58(1988).
20. R.F. Mattrey, WW Peck, RA Slutsky, CB Higgins. Perfluoroctylbromide as a Blood Pool Imaging Agent for Computed Tomography. J Comput Assist Tomogr 8:739-744 (1984).
21. B.J. Hillman, ML Stanley, P Tracey, et al. CT Determination of Renal and Hepatic Microvascular Volumes in Experimental Acute Renal Failure. Invest Radiol 17:41-45 (1982)
22. R.F. Mattrey: Potential role of Perfluorooctylbromide in the Detection and Characterization of Liver Lesions with CT. Radiology. 170:18-20 (1989).
23. R.F. Mattrey, DM Long, F Multer, et al. Perfluoroctylbromide: A Reticuloendothelial Specific and a Tumor Imaging Agent for Computed Tomography. Radiology 145:755-758 (1982).
24. M. Vermess, JL Doppman, PH Sugarbaker, et al. Computed Tomography of The Liver and Spleen with Intravenous Lipoid Contrast Material: Review of 60 Examinations. AJR 138:1063-1071 (1982).
25. P.H. Sugarbaker, M Vermess, et al. Improved Detection of Focal Lesions with Computerized Tomographic Examination of the Liver Using Ethiodized Oil Emulsion (EOE-13) Liver Contrast. Cancer 54:1489-95 (1984).
26. N. Patronas, DL Miller, M Girton. Experimental Comparison of EOE-13 and Perfluoroctylbromide for The CT Detection of Hepatic Metastases. Invest Radiol 19:570-573 (1984)
27. G.C. Steinbach, GM Lim, RS Arellano, et al. The Use of Imagent BP as a Blood Pool Contrast Agent to Visualize and Quantitate Liver Tumor Burden. ISBS 1993, San Diego. These Proceedings
28. K.G. Baker, R Wrigley, HB Saunders, RF Mattrey. Efficacy of Imagent BP at 1.5mL/kg in a Rabbit Liver Tumor Model. ISBS 1993, San Diego. These Proceedings
29. V. Sanchez, L Zarif, J Greiner, et al. Novel Injectable Fluorinated Contrast Agents with Enhanced Radiopacity. ISBS 1993, San Diego. These Proceedings
30. G. Adam, RW Gunther, C Schiffer, et al. Computed Tomographic Enhancement of the Liver, Liver Abscesses, Spleen, and Major Vessels with Perfluorooctylbromide Emulsion. Influence of Dosage and Injection Velocity in an Animal Model. Invest Radiol 27:698-705 (1992).
31. R.F. Mattrey, R Mitten, T Peterson, CD Long. Vascular Ultrasonic Enhancement of Tissues with Perfluoroctylbromide for Renal Tumor Detection (abstr) Radiology 165(Supp):76 (1987).
32. A.V. Ratner, HH Muller, B Bradley-Simpson, et al. Detection of Tumors with 19F Magnetic Resonance Imaging. Invest Radiol 23:361-4 (1988).
33. R.F. Mattrey, MP Andre, J Campbell, et al. Specific Enhancement of Intra-Abdominal Abscesses with Perfluoroctylbromide for Computed Tomography. Invest Radiol 19:438-446 (1984).
34. M.L. Miller, D Stinnett, LC Clark Jr. Ultrastructure of Tumoricidal Peritoneal Exudate Cells Stimulated In-vivo by Perfluorochemical Emulsions. J. Reticuloendothelial Soc 27:105-18 (1980).
35. R.F. Mattrey, JJ Brown, RE Shelton, et al. Use of Perfluorooctylbromide (PFOB) to Detect Liver Abscesses with CT: Safety and Efficacy. Invest Radiol. 26:792-798(1991).
36. R.F. Mattrey, FW Scheible, BB Gosink, et al. Perfluoroctylbromide: A Liver and Spleen Specific and a Tumor Imaging Ultrasound Contrast Material. Radiology 145:759-762 (1982)
37. R.F. Mattrey, GR Leopold, E. van Sonnenberg, et al. Perfluorochemicals as Liver and Spleen Seeking Ultrasound Contrast Agents. J Ultrasound Med 2:173-176(1983).
38. R.F. Mattrey, MP Andre. Ultrasonic Enhancement of Myocardial Infarction with Perfluorocarbon Compounds. Amer J Cardiol 54:206-210 (1984)
39. R.F. Mattrey, G Strich, RE Shelton, et al. Perfluorochemicals as Ultrasound Contrast Agents for Tumor Imaging and Hepatosplenography: Preliminary Clinical Results. Radiology 163:339-443 (1987).
40. D.J. Sartoris, J Guerra Jr, RF Mattrey, et al. Perfluoroctylbromide as a Contrast Agent for Computed Tomographic Imaging of Septic and Aseptic Arthritis. Invest Radiol 21:49-55 (1986).
41. G. Wolf, DM Long, JG Riess. Percutaneous Lymphography with Perfluoroctyl bromide Emulsions. Presented at the annual meeting of Radiological Society of North America, Chicago 1990. Radiology 177 (P):366 (1990).
42. F. Ikomi, G Hanna, GW Schmid-Schonbein. Intracellular and Extracellular Transpport of Perfluorocarbon Emulsion From Subcutaneous Tissue to Regional Lymphatics. ISBS 1993, San Diego. These Proceedings
43. G. Hanna, D Saewert, J Shorr, et al. Preclinical and Clinical Studies on Lymphnode Imaging Using Perflubron Emulsion. ISBS 1993, San Diego. These Proceedings
44. P.L. Hilpert, RF Mattrey, R Mitten, T Peterson. Intravenous Ultrasonic Contrast Agents to Enhance Systemic Arterial Doppler Signal. Presented at the annual meeting of the Association of University Radiologists, New Orleans, May 1988
45. B.D. Coley, RF Mattrey, A Roberts, SF Keane: The Potential Role of PFOB Enhanced Sonography of the Kidney: PART II - Detection of Partial Infarction. Kidney International. 39:740-745 (1990).
46. B.D. Coley, RF Mattrey, R Mitten, T Peterson: The Physiologic Basis of the Radiodense Renal Medulla After the Administration of Blood Pool Contrast Agent, PFOB Invest Radiol. 25:1287-1293 (1990).
47. D. Munzing, RF Mattrey, VM Reznik, et al. The Potential Role of PFOB Enhanced Sonography of the Kidney: PART I - Detection of Renal Function and Acute Tubular Necrosis. Kidney International. 39:733-739 (1990).
48. G.M. Lim, BD Coley, RS Arellano, RF Mattrey: Perflubron Emulsion Allows Sonographic Distinction of Normal from Obstructed Kidneys. Presented at the annual meeting of Radiological Society of North America, Chicago 1992. Radiology 185 (P):287 (1992).
49. M. Behan, D O'Connell, RF Mattrey, DN Carney. Perfluorooctylbromide As a Contrast Agent For Sonography and Computed Tomography. AJR 160:399-405 (1993).
50. R. Satterfield, VM Tarter, DJ Schumacher, et al. Comparison of Different Perfluorocarbons as Ultrasound Contrast Agents. Invest Rad 28:325-331 (1993).